CardioComm Solutions, Inc.

PNK:EKGGF

$0.01295 USD

$0.0 (30.15%)

Volume
1K
Average Volume
328
Market Capitalization
$2.5M
P/E Ratio
-19.44
Dividend Yield
0.00%
Price Target
$
Year High
$0.02
Year Low
$0.00
Payout Ratio
$0.00
Current Ratio
$0.34

Industry, Sector & symbol

Stock Exchange Other OTC
CEO Mr. Etienne Grima CHE, MSc
Industry Medical - Healthcare Information Services
Sector Healthcare
Current Symbol EKGGF
CUSIP None
CIK None
Web https://www.cardiocommsolutions.com
Phone None
Currency USD
Employees None
Country CA

Liquidity

Debt-to-Equity Ratio -0.75
Payout Ratio 0.00
Current Ratio 0.34
Quick Ratio 0.29
Cash Ratio 0.01

Sales & Book Value

Annual Sales $876.41K
Price / Sales 5.44
Cash Flow 0.00
Price / Cash Flow -20.67
Price / Book -5.21

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating Sell
Rating Score(0-5) 2
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $-0.0006
Trailing P/E Ratio -19.44
PEG Ratio 0.19
P/E Growth 0.19
Net Income $-97326
Net Margin -21.94%
Pretax Margin -21.94%
Return on Equity 29.61%
Return on Assets -39.41%

Financials Score

AltmanZ Score -139.62
Piotroski Score 1.00
Working Capital -558.31K
Total Assets 357.99K
Ebit -356.09K
Market Cap 2.5M
Total Liabilities 884.67K

Poll Results

About CardioComm Solutions, Inc. (PNK:EKGGF) Stock

CardioComm Solutions, Inc. develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide. The company's technology is used in a range of products for the recording, transmission, viewing, analyzing, reporting, and storage of ECGs for arrhythmia screening, diagnosis, and management of cardiac patients. Its proprietary device connectivity and ECG management technologies are used in medical, consumer, clinical research, and telemedicine solutions. The company's software products include Global ECG Management System (GEMS), a software solution for cardiac event monitoring; GlobalCardio 12 Lead, a web enabled ECG device that is EMR compatible; and G ... EMS Lite for Windows, an electronic ECG receiving system. It also offers software modules, such as GEMS WIN Air, a live wireless ECG monitoring solution; AutoAttendant, which allows healthcare providers to focus on providing patient care; GEMS HL7 Interface that allows patient and follow-up information to be sent in an HL7 message format to other EMR systems that are HL7 compliant; and GlobalCardio EMR integration that enables bidirectional movement of data, including patient information, reports, and links. In addition, the company provides hardware products comprising HeartCheck PEN and HeartCheck, which are handheld ECG monitors; and Sirona telephonic and wireless event recorders, as well as HeartCheck CardiBeat. Further, it offers ASP services, including C4 ECG management services; and HeartCheck SMART Monitoring. Additionally, the company provides other products comprising GlobalCardio 3 Lead; ECG Viewer SDK; QRS Diagnostic; and QRS 12 Lead Universal products. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada.

CardioComm Solutions Integrates ECG Technology into Sony's mSafety Platform

2024-11-11 08:59:00

Collaboration Brings Advanced ECG Monitoring to Sony's Wearable Health Solution Toronto, Ontario--(Newsfile Corp. - November 11, 2024) - CardioComm Solutions, (TSXV: EKG) a global leader in medical electrocardiogram (ECG) monitoring technology and a pioneer in Remote Patient Monitoring (RPM) solutions, is pleased to confirm a technology partnership with Sony to integrate CardioComm's ECG technology into the Sony mSafety platform. The addition of CardioComm's technologies will enhance Sony's wearable health solution, delivering a seamless ECG monitoring experience to users without the need for a smartphone.

CardioComm Solutions Awarded Canadian Space Agency Contract for Design of Next Generation Connected Care Medical Module Prototype

2024-10-16 13:29:00

GEMS(TM) C2M2 will Detect, Diagnose, Treat and Monitor Health Conditions for Use in Space Missions and in Remote Communities on Earth. Toronto, Ontario--(Newsfile Corp. - October 16, 2024) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider and pioneer of Remote Patient Monitoring (RPM) solutions for direct-to-consumer heart monitoring and prescribed ambulatory electrocardiogram ("ECG") software and hardware solutions, is pleased to announce it has been awarded, through a competitive process, up to $150,000 in funding from the Canadian Space Agency (CSA) for design of the next generation prototype for the CSA's Connected Care Medical Module (C2M2)1.

CardioComm Solutions Secures Health Canada Clearance for Artificial Intelligence ECG Interpretation for Multiple Cardiac Arrhythmias

2024-09-30 20:26:00

GEMS(TM) Rhythm AI Clearance will Address Event, Holter and Long-Term Continuous ECG Monitoring Needs for Remote Patient Monitoring in Canada Toronto, Ontario--(Newsfile Corp. - September 30, 2024) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software and hardware solutions, is pleased to announce it has received Health Canada clearance of its GEMS™ Rhythm ECG artificial intelligence (AI) software for the automated detection of multiple arrhythmias and morphology abnormalities. The GEMS Rhythm arrhythmia and morphology abnormality AI detection will include atrial fibrillation, prolonged QT and QTc intervals, tachycardia/bradycardia/pause, average heart rate, PQ and QRS intervals, identification of patterns of different heart beats such as PACs, PVCs, bigeminy and trigemini, as well as estimation of the heart rate variability.

CardioComm Solutions, Inc. Secures Exclusive Distribution Rights in Quebec for ECG Medical Devices

2024-08-28 18:04:00

Deal enhances access to long term continuous ECG monitoring devices for Canadians Toronto, Ontario--(Newsfile Corp. - August 28, 2024) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software and hardware solutions, is pleased to announce an exclusivity agreement for the Province of Quebec for the sale and distribution of TZ Medical Inc. ("TZM") ECG monitoring devices used for standard and extended Holter and cardiac arrhythmia monitoring. CardioComm has had a long-standing relationship with the hardware manufacturer, Oregon-based TZM, and is a non-exclusive distributor for TZM's ECG monitoring medical devices in Canada and the US.

CardioComm Solutions Enters Loan Agreement

2024-07-22 21:47:00

Toronto, Ontario--(Newsfile Corp. - July 22, 2024) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a global medical provider of consumer heart monitoring and medical electrocardiogram ("ECG") software solutions, announces that it has entered into a revolving line-of-credit loan agreement with a company (the "Lender") controlled by Daniel Grima, a director of CardioComm dated as of July 22, 2024, representing additional available funding as needed of up to $500,000. The terms of the loan require that any borrowed amounts be repaid by the Company, along with interest at 8% per year, by no later than July 22, 2026.

Frequently Asked Questions

What is the current CardioComm Solutions, Inc. (EKGGF) stock price?

CardioComm Solutions, Inc.(PNK:EKGGF) stock price is $0.01295 in the last trading session. During the trading session, EKGGF stock reached the peak price of $4 while $6.0E was the lowest point it dropped to. The percentage change in EKGGF stock occurred in the recent session was 30.15% while the dollar amount for the price change in EKGGF stock was $0.0.

EKGGF's industry and sector of operation?

The PNK listed EKGGF is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector.

Who are the executives of EKGGF?

Mr. Robert E. Caines | Chairman & Chief Financial Officer
Dr. Branislav Vasilijevic Ph.D. | Director of Software Engineering & Director
Mr. Etienne Grima CHE, MSc | Chief Executive Officer, Corporate Secretary & Director
|
|

How many employees does EKGGF have?

Number of EKGGF employees currently stands at None. EKGGF operates from 18 Wynford Drive, Toronto, ON M3C 3S2, CA.

Link for EKGGF official website?

Official Website of EKGGF is: https://www.cardiocommsolutions.com

How do I contact EKGGF?

EKGGF could be contacted at phone #None and can also be accessed through its website. EKGGF operates from 18 Wynford Drive, Toronto, ON M3C 3S2, CA.

How many shares of EKGGF are traded daily?

The average number of EKGGF shares traded daily for last 3 months was 328.

What is the market cap of EKGGF currently?

The market value of EKGGF currently stands at $2.5M with its latest stock price at $0.01295